Some studies [93,94,95] have shown that CD11b−, as well as CD11b+ DCs, migrate to tumour-draining lymph nodes, activate naïve T cells, and promote their expansion, leading to antitumour immunity. The gene discussed is ITGAM; the disease is neoplasm.